SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-22-008323
Filing Date
2022-11-10
Accepted
2022-11-10 16:45:37
Documents
49
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q celz_10q.htm   iXBRL 10-Q 922057
2 CERTIFICATION celz_ex311.htm EX-31.1 11301
3 CERTIFICATION celz_ex312.htm EX-31.2 11180
4 CERTIFICATION celz_ex321.htm EX-32.1 4518
5 CERTIFICATION celz_ex322.htm EX-32.2 4507
11 celz_10qimg1.jpg GRAPHIC 21615
  Complete submission text file 0001477932-22-008323.txt   3663120

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA celz-20220930.xsd EX-101.SCH 46875
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE celz-20220930_lab.xml EX-101.LAB 248275
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celz-20220930_cal.xml EX-101.CAL 38841
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celz-20220930_pre.xml EX-101.PRE 197120
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celz-20220930_def.xml EX-101.DEF 108678
43 EXTRACTED XBRL INSTANCE DOCUMENT celz_10q_htm.xml XML 387124
Mailing Address 211 E. OSBORN RD. PHOENIX AZ 85012
Business Address 211 E. OSBORN RD. PHOENIX AZ 85012 480-399-2822
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001187953 (see all company filings)

IRS No.: 870622284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41120 | Film No.: 221378082
SIC: 2836 Biological Products, (No Diagnostic Substances)